NasdaqGS:GENBBiotechs
Assessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x
Stock performance snapshot
Generate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods, including a small move over the past month and a gain over the past 3 months.
See our latest analysis for Generate Biomedicines.
Recent trading has been choppy, with a 7 day share price return of down 9.7% contrasting with a 90 day share price return of up 10.0%. This suggests short term momentum is cooling...